Stock Analiz

Mesoblast Ltd. (MESO) financials: revenue, earnings and cash flow

Fiscal 2016–2025 · from SEC filings · data as of November 13, 2026

Summary

Mesoblast’s revenue went from $43M in fiscal 2016 to $17M in fiscal 2025, a decline of about 9.6% a year.

Net income in fiscal 2025 was -$102M, a net margin of -593.9%; the best year in this period was 2016 with -$4M.

Free cash flow was -$51M in fiscal 2025 and positive in 0 of the 10 years shown.

Revenue, profit and cash flow by year

Revenue
2016: $43M162017: $2M172018: $17M182019: $17M192020: $32M202021: $7M212022: $10M222023: $8M232024: $6M242025: $17M25$17M
Net income
2016: -$4M162017: -$77M172018: -$35M182019: -$90M192020: -$78M202021: -$99M212022: -$91M222023: -$82M232024: -$88M242025: -$102M25-$102M
Free cash flow
2023: -$64M20232024: -$49M20242025: -$51M2025-$51M
EPS (diluted)
2016: $-0.03162017: $-0.59172018: $-0.27182019: $-0.69192020: $-0.60202021: $-0.76212022: $-0.70222023: $-0.63232024: $-0.68242025: $-0.7925$-0.79

Income statement

Fiscal year2025202420232022202120202019201820172016
Revenue$17M$6M$8M$10M$7M$32M$17M$17M$2M$43M
Gross profit$12M$6M$8M———————
Operating income-$80M-$67M-$63M———————
Net income-$102M-$88M-$82M-$91M-$99M-$78M-$90M-$35M-$77M-$4M
EPS (diluted)$-0.79$-0.68$-0.63$-0.70$-0.76$-0.60$-0.69$-0.27$-0.59$-0.03
R&D——————————
Revenue growth+191.4%−21.3%−26.5%+37.4%−76.9%+92.3%−3.6%+618.9%−94.3%—

Cash flow

Fiscal year2025202420232022202120202019201820172016
Operating cash flow-$50M-$48M-$63M-$66M-$101M-$50M-$58M-$75M-$95M-$88M
Capital spending-$680000-$271000-$264000———————
Free cash flow-$51M-$49M-$64M———————
Dividends paid$0$0$0$0$0$0$0$0$0$0
Buybacks——————————
Stock-based pay$22M$6M$4M$6M$13M$8M$4M$6M$5M$3M

Balance sheet

Fiscal year2025202420232022202120202019201820172016
Cash$162M$63M$71M$60M$137M$129M$50M$38M$46M$81M
Debt$122M$114M$109M$97M$94M$89M$81M$59M$0—
Equity$597M$480M$502M$497M$581M$549M$481M$546M$517M$528M
Total assets$785M$669M$669M$662M$745M$734M$652M$692M$656M—
Shares (diluted)130M130M130M130M130M130M130M130M130M130M

Margins and returns

Fiscal year2025202420232022202120202019201820172016
Gross margin70.2%100.0%100.0%———————
Operating margin-465.5%-1143.5%-835.3%———————
Net margin-593.9%-1490.3%-1091.7%-894.6%-1329.2%-242.4%-537.0%-203.5%-3184.7%-9.7%
FCF margin-294.4%-825.6%-847.0%———————
ROIC-8.8%-11.3%-10.2%———————
ROE-17.1%-18.3%-16.3%-18.4%-17.0%-14.2%-18.7%-6.5%-14.9%-0.8%

Frequently asked questions

What is Mesoblast’s annual revenue?

$17M in fiscal 2025.

How much profit does Mesoblast make?

Net income was -$102M in fiscal 2025 (net margin -593.9%).

Is Mesoblast’s revenue growing?

Yes: revenue rose 191.4% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.